David Baranowski

837 total citations
15 papers, 649 citations indexed

About

David Baranowski is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, David Baranowski has authored 15 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in David Baranowski's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Nerve injury and regeneration (3 papers). David Baranowski is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Amyotrophic Lateral Sclerosis Research (4 papers) and Nerve injury and regeneration (3 papers). David Baranowski collaborates with scholars based in Canada and United States. David Baranowski's co-authors include Denis G. Kay, Babykumari P. Chitramuthu, H.P.J. Bennett, Jackalina M. Van Kampen, Christopher A. Shaw, Benoît Cadieux, Joseph Gabriele, Andrew Bateman, Jonathan Zuccolo and Qingfang Meng and has published in prestigious journals such as PLoS ONE, Journal of Neurochemistry and BMC Genomics.

In The Last Decade

David Baranowski

15 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Baranowski Canada 12 252 171 170 113 80 15 649
Maxx P. Horowitz United States 6 177 0.7× 223 1.3× 101 0.6× 268 2.4× 35 0.4× 6 748
Anna Wuolikainen Sweden 14 462 1.8× 375 2.2× 176 1.0× 59 0.5× 158 2.0× 18 875
Brian C. Kramer United States 16 163 0.6× 199 1.2× 53 0.3× 61 0.5× 100 1.3× 26 670
Wei-Dong Le China 15 302 1.2× 403 2.4× 135 0.8× 56 0.5× 51 0.6× 24 936
Toni Ahtoniemi Finland 9 128 0.5× 191 1.1× 194 1.1× 44 0.4× 46 0.6× 11 473
Daniel Cacabelos Spain 14 325 1.3× 387 2.3× 196 1.2× 43 0.4× 127 1.6× 19 875
Jianqing Ding China 14 279 1.1× 339 2.0× 232 1.4× 79 0.7× 21 0.3× 30 896
Linsen Hu China 12 128 0.5× 401 2.3× 95 0.6× 63 0.6× 26 0.3× 18 710
Kayo Matsumoto Japan 16 330 1.3× 323 1.9× 177 1.0× 42 0.4× 21 0.3× 31 869
Jiyu Lou China 12 64 0.3× 264 1.5× 115 0.7× 51 0.5× 117 1.5× 37 629

Countries citing papers authored by David Baranowski

Since Specialization
Citations

This map shows the geographic impact of David Baranowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Baranowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Baranowski more than expected).

Fields of papers citing papers by David Baranowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Baranowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Baranowski. The network helps show where David Baranowski may publish in the future.

Co-authorship network of co-authors of David Baranowski

This figure shows the co-authorship network connecting the top 25 collaborators of David Baranowski. A scholar is included among the top collaborators of David Baranowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Baranowski. David Baranowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rathbone, Michel P., Joseph Gabriele, David Baranowski, et al.. (2021). Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients. Alzheimer Disease & Associated Disorders. 36(3). 269–271. 4 indexed citations
2.
Rathbone, Michel P., et al.. (2019). Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Stroke Patients. Journal of Stroke and Cerebrovascular Diseases. 29(1). 104502–104502. 9 indexed citations
3.
Gabriele, Joseph, et al.. (2019). Stability, Activity, and Application of Topical Doxycycline Formulations in a Diabetic Wound Case Study.. PubMed. 31(2). 49–54. 11 indexed citations
4.
Meng, Qingfang, et al.. (2018). A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products. PLoS ONE. 13(5). e0196396–e0196396. 81 indexed citations
5.
Baranowski, David, et al.. (2018). Penetration and efficacy of transdermal NSAIDs in a model of acute joint inflammation. Journal of Pain Research. Volume 11. 2809–2819. 19 indexed citations
6.
Baranowski, David, et al.. (2018). LivRelief varicose veins cream in the treatment of chronic venous insufficiency of the lower limbs: A 6-week single arm pilot study. PLoS ONE. 13(12). e0208954–e0208954. 4 indexed citations
7.
Meng, Qingfang, et al.. (2018). Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine. PLoS ONE. 13(3). e0194979–e0194979. 30 indexed citations
8.
Kampen, Jackalina M. Van, David Baranowski, H.A. Robertson, Christopher A. Shaw, & Denis G. Kay. (2015). The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease. PLoS ONE. 10(10). e0139694–e0139694. 34 indexed citations
9.
Kampen, Jackalina M. Van, David Baranowski, & Denis G. Kay. (2014). Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease. PLoS ONE. 9(5). e97032–e97032. 61 indexed citations
10.
Kampen, Jackalina M. Van, David Baranowski, Christopher A. Shaw, & Denis G. Kay. (2013). Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease. Experimental Gerontology. 50. 95–105. 62 indexed citations
11.
Chitramuthu, Babykumari P., David Baranowski, Denis G. Kay, Andrew Bateman, & H.P.J. Bennett. (2010). Progranulin modulates zebrafish motoneuron development in vivoand rescues truncation defects associated with knockdown of Survival motor neuron 1. Molecular Neurodegeneration. 5(1). 41–41. 47 indexed citations
12.
Chitramuthu, Babykumari P., David Baranowski, Benoît Cadieux, et al.. (2010). Molecular cloning and embryonic expression of zebrafish PCSK5 co‐orthologues: Functional assessment during lateral line development. Developmental Dynamics. 239(11). 2933–2946. 14 indexed citations
13.
Baranowski, David, Babykumari P. Chitramuthu, Suneil Malik, et al.. (2009). Progranulin is expressed within motor neurons and promotes neuronal cell survival. BMC Neuroscience. 10(1). 130–130. 132 indexed citations
14.
Poirier, Steve, Annik Prat, Joanne Paquin, et al.. (2006). Implication of the proprotein convertase NARC‐1/PCSK9 in the development of the nervous system. Journal of Neurochemistry. 98(3). 838–850. 99 indexed citations
15.
Cadieux, Benoît, Babykumari P. Chitramuthu, David Baranowski, & H.P.J. Bennett. (2005). The zebrafish progranulin gene family and antisense transcripts. BMC Genomics. 6(1). 156–156. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026